Healthcare Startup Launches New Clinical Research Development Model Focused on Patient-Centered Designs

ARLINGTON, Va., Sept. 9, 2014 /PRNewswire/ -- HealthiVibe, LLC, a newly formed company, aims to pioneer a new model in which the patient voice becomes central to clinical trial development.  Founded by Abbe Steel, a 23-year veteran of the pharmaceutical industry, HealthiVibe uses a novel approach to gathering patient feedback.

"We believe our business has a chance at truly disrupting the status quo in clinical research development, and will result in more patient-centered designs and faster, less expensive clinical research," said Abbe Steel, Founder and Chief Executive Officer.

The new company will speak at the 4th Annual Dpharm: Disruptive Innovations to Advance Clinical Trials Conference at The Fairmont Copley Plaza in Boston. HealthiVibe's two sessions are scheduled for Wednesday, September 10, 2014 at 11:50am and Friday, September 12 at 10:30am. Participants include representatives from leading practitioners in Pharma R&D with a focus on clinical research, along with innovative leaders from other industries.

"We are thrilled to be participating in the Dpharm event," Steel said.  "By partnering with our biopharmaceutical clients and working to fully integrate the concept of patient centricity in clinical development, we hope to leverage new models to advance the promise and challenge of innovation in drug development."

About HealthiVibe, LLC

HealthiVibe offers a systematic, structured process for pharmaceutical manufacturers to obtain valuable patient insights around clinical trial design and patient-centered initiatives. The company is guided by the premise that patients should play a more instrumental and active role in clinical studies before they're designed and conducted—and throughout the entire patient journey. HealthiVibe obtains rich, real-time feedback through interactive patient advisory boards and focus groups, conducts mock clinical trial simulations and utilizes online, crowdsourced surveys from a 10 million patient panel to reach a broader, more representative patient audience.

About Dpharm: Disruptive Innovations to Advance Clinical Trials

Dpharm is the only conference dedicated to exploring and addressing significant innovation in clinical trials. Sponsored by The Conference Forum, this event brings together an exceptional audience of out-of-the-box thinkers determined to make clinical trials more affordable, efficient, with higher quality data and a far better experience for patients. For more information visit: http://theconferenceforum.org/conferences/disruptive-innovations/overview/.

SOURCE HealthiVibe, LLC